Skip to content

Clinical trials

Completed Phase 2/3 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2/3 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20042
20071
20091
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Austrian Forum Against Cancer1
Bristol-Myers Squibb1
Celgene1
Janssen Research & Development, LLC1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Royal Marsden NHS Foundation Trust1
Tampere University Hospital1
University of Arkansas1
Vejle Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma11
Neoplasms, Plasma Cell3
Hodgkin Disease1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.